Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10464)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
PCBP3
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
| In total 1 item(s) under this target | |||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
| Responsed Disease | Pancreatic cancer | ICD-11: 2C10 | |||
| Pathway Response | Ferroptosis | hsa04216 | |||
| PI3K-Akt signaling pathway | hsa04151 | ||||
| Fatty acid metabolism | hsa01212 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| Cell migration | |||||
| Cell invasion | |||||
In Vitro Model |
PANC-1 cells | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
| AsPC-1 cells | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0152 | ||
| HPDE cells | Normal | Homo sapiens | CVCL_4376 | ||
| In Vivo Model |
Male BALB/c nude mice (5 weeks old; 16-18 g) were obtained from the Animal Center of Guangxi Medical University and grown under specific pathogen-free conditions. The mice (n = 20) were randomly divided into four groups; Vector group, A2M-AS1 group, Vector + Erastin group, and A2M-AS1 + Erastin group. The Vector and Vector + Erastin groups were injected with 106 cells that stably expressing the lentiviral vector, whereas the other two groups were injected with 106 cells that stably overexpressing A2M-AS1. On the 7th day after inoculation, the Vector + Erastin and A2M-AS1 + Erastin groups were intraperitoneally injected with a 100-uL Erastin solution (40 mg/kg) once every 2 days.
Click to Show/Hide
|
||||
| Response regulation | A2M-AS1 could directly interact with the poly (rC) binding protein 3 (PCBP3), which plays an important role in the process of iron metabolism, thereby promoting the ferroptosis in pancreatic cancer. | ||||
Pancreatic cancer [ICD-11: 2C10]
| In total 1 item(s) under this disease | |||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
| Target Regulator | Poly(rC)-binding protein 3 (PCBP3) | Protein coding | |||
| Pathway Response | Ferroptosis | hsa04216 | |||
| PI3K-Akt signaling pathway | hsa04151 | ||||
| Fatty acid metabolism | hsa01212 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| Cell migration | |||||
| Cell invasion | |||||
In Vitro Model |
PANC-1 cells | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
| AsPC-1 cells | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0152 | ||
| HPDE cells | Normal | Homo sapiens | CVCL_4376 | ||
| In Vivo Model |
Male BALB/c nude mice (5 weeks old; 16-18 g) were obtained from the Animal Center of Guangxi Medical University and grown under specific pathogen-free conditions. The mice (n = 20) were randomly divided into four groups; Vector group, A2M-AS1 group, Vector + Erastin group, and A2M-AS1 + Erastin group. The Vector and Vector + Erastin groups were injected with 106 cells that stably expressing the lentiviral vector, whereas the other two groups were injected with 106 cells that stably overexpressing A2M-AS1. On the 7th day after inoculation, the Vector + Erastin and A2M-AS1 + Erastin groups were intraperitoneally injected with a 100-uL Erastin solution (40 mg/kg) once every 2 days.
Click to Show/Hide
|
||||
| Response regulation | A2M-AS1 could directly interact with the poly (rC) binding protein 3 (PCBP3), which plays an important role in the process of iron metabolism, thereby promoting the ferroptosis in pancreatic cancer. | ||||
